Abstract:Background: As high throughput sequencing (HTS) technique advances, it has been widely used in cancer research. More specifically, HTS enables genome-wide detection of somatic alterations which implicate the dynamic of cancer development as well as therapeutic strategy. However, a number of complications, such as sample tissue lesion, imperfect experimental procedure and nucleotide polymorphism between individual, often induce non-somatic noise and jeopardize the detection of somatic alterations. We present a validated computational pipeline that allows accurate somatic alteration identification. Method: We created a number of cell line mixture samples and sequenced at averagely 1500x depth. Each mixture sample was composed of cell lines with pre-specified proportion in order to represent distinct tumor purity and clonality. Prior to mixture creation, variant candidates in each cell line sample were labeled as one of three categories: germline variant of high confidence, artifact or blacklist (excluded from future assessment). The categorization was based on HaplotypeCaller results followed by a series of quality control. The allele frequency distribution of germline variants from each cell line was validated in mixture samples. We used MuTect as prototype pipeline and implemented further optimization on a number of parameter settings in a supervised fashion. Lastly, the optimized pipeline was evaluated using an independent dataset and its performance was compared with a number of alternative variant callers. Result: Our benchmark showed that default parameter setting of ‘alt_allele_in_normal' and ‘nearby_gap_events' in MuTect were over-strict. 73% of variants rejected by these parameters were actually real somatic variants. We believed that, instead of using constant as parameter settings, the optimum parameters should be trained on data with similar sequencing depth. We therefore re-configured the parameters using logistic regression. Furthermore, minimum supporting depth and minimum allele frequency were determined by AUROC. With optimized pipeline, we were able to achieve 96% sensitivity and 2/M false positive rate (FPR) compared with 90% sensitivity and 8/M FPR using default parameters. We further tested the optimized pipeline in an independent dataset and compared the performance with several well-known variant callers including MuSE, VarScan2, Strelka, LoFreq, VarDict and MuTect2. The performance of each caller was ranked as following: our optimized pipeline > MuTect > MuTect2/Strelka/LoFreq > Muse > VarScan2/VarDict. Citation Format: Cheng Yan, Yingjiang Ye, Weihua Guo, Junhui Yang, Yufei Yang. An improved computational pipeline for tumor somatic alterations detection [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2021; 2021 Apr 10-15 and May 17-21. Philadelphia (PA): AACR; Cancer Res 2021;81(13_Suppl):Abstract nr 151.

Integrated Modeling of GC-Content, Mappability, Tumor Impurity and Aneuploidy for Accurate Detection of Genomic Aberrations.

GPHMM: an Integrated Hidden Markov Model for Identification of Copy Number Alteration and Loss of Heterozygosity in Complex Tumor Samples Using Whole Genome SNP Arrays

A novel HMM for analyzing chromosomal aberrations in heterogeneous tumor samples

CLImAT: Accurate Detection of Copy Number Alteration and Loss of Heterozygosity in Impure and Aneuploid Tumor Samples Using Whole-Genome Sequencing Data

An Innovative Data Analysis Strategy For Accurate NGS Detection of Tumor mtDNA Mutations

Enhanced Bayesian detection for copy number alterations from next-generation sequencing data.

Mixhmm: Inferring Copy Number Variation And Allelic Imbalance Using Snp Arrays And Tumor Samples Mixed With Stromal Cells

SAAS-CNV: A Joint Segmentation Approach on Aggregated and Allele Specific Signals for the Identification of Somatic Copy Number Alterations with Next-Generation Sequencing Data.

An innovative data analysis strategy for accurate next-generation sequencing detection of tumor mitochondrial DNA mutations

A novel framework for analyzing somatic copy number aberrations and tumor subclones for paired heterogeneous tumor samples

Identification of Genomic Aberrations in Cancer Subclones from Heterogeneous Tumor Samples

Comprehensive and realistic simulation of tumour genomic sequencing data

Genome-Wide Identification of Somatic Aberrations from Paired Normal-Tumor Samples

A computational framework to unify orthogonal information in DNA methylation and copy number aberrations in cell-free DNA for early cancer detection

Accurate Estimation of Genomic Deletions and Normal Cell Contamination by Bayesian Analysis of Mixtures

Modeling and Correct the GC Bias of Tumor and Normal WGS Data for SCNA Based Tumor Subclonal Population Inferring

Abstract 151: an Improved Computational Pipeline for Tumor Somatic Alterations Detection

Detecting somatic point mutations in cancer genome sequencing data: a comparison of mutation callers

A graph-based algorithm for estimating clonal haplotypes of tumor sample from sequencing data

A Computational Framework To Simultaneously Quantify Dna Methylation, Somatic Copy Number Alternation And Dna Heterogeneity From Low Coverage Plasma Circulating Dna Sequencing

Accurately Estimating Tumor Purity Of Samples With High Degree Of Heterogeneity From Cancer Sequencing Data